登革热病毒感染:免疫反应和治疗点
Ngo Tin Ern1, Thamil Vaani Komarasamy1, Nur Amelia Azreen Adnan1
1Infection and Immunity Research Strength, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Malaysia.
登革热病毒 (DENV) 感染由于其严重程度和复杂的免疫反应,构成了全球健康威胁. 准高运动性组盒1 (HMGB1) 和NLRP3炎症酶途径提供了潜在的治疗策略,以减少疾病的严重程度.
科学领域:
- 免疫学和病毒学
- 分子生物学分子生物学
背景情况:
- 登革热病毒 (DENV) 感染是一个重要的全球健康问题,发病率和死亡率很高.
- DENV免疫反应具有悖论性,有助于病毒清除和严重疾病,由血清型之间的交叉反应加剧.
- 由于DENV血清型的复杂性,开发一种通用黄状病毒疫苗具有挑战性.
研究的目的:
- 审查高运动性组框1 (HMGB1) 和NLRP3炎症酶激活在DENV病变发生中的作用.
- 突出显示HMGB1和NLRP3炎症酶抑制剂作为DENV感染的潜在治疗点.
主要方法:
- 文献综述侧重于DENV诱导的炎症和细胞死亡的分子机制.
- 对涉及核因子kB (NF-kB) 和促炎细胞因子IL-1β和IL-18的下游信号通路的分析.
- 检查NLRP3在细胞亡和热亡中的作用.
主要成果:
- HMGB1和NLRP3炎症酶激活是DENV感染中炎症反应的关键驱动因素.
- 这些途径通过NF-κB激活导致IL-1β和IL-18的释放.
- NLRP3炎症酶激活有助于细胞亡和热亡,可能导致全身衰竭.
结论:
- 了解DENV感染的免疫病原发生有了显著的进步.
- HMGB1和NLRP3炎症酶抑制剂代表了减轻DENV疾病严重性的有希望的治疗途径.
- 虽然缺乏有效的抗病毒药物或疫苗,但免疫调节方法为管理DENV感染提供了希望.
更多相关视频
08:36Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction
Published on: November 1, 2018
06:00Author Spotlight: Development of a Smartphone-Enhanced Paper-Based Device for Rapid Dengue NS1 Detection
Published on: January 26, 2024
相关概念视频
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Cross-reactivity
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Allergic Drug Reactions
Microorganisms in Medicine and Therapeutics
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
